The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
Our client company has developed an innovative frozen lozenge technology designed to deliver pharmaceuticals and OTC products, which offers a new alternative administration method for paediatric and otherwise difficult to swallow therapeutics. More